The effect of long-term low-dose diphosphonate treatment on rat bone

C. R. Dunstan, E. Hills, R. A. Evans, C. Rolfe Howlett

    Research output: Contribution to journalArticlepeer-review

    28 Citations (Scopus)


    Weanling, male rats were given ethane-1-hydroxy 1,1-diphosphonate (EHDP) or dichloromethylene diphosphonate (Cl2MDP) 0.5 mgP/kg/day for 140 days. Samples prepared after sacrifice were: (1) thin ground (30 μm) transverse tibial sections, (2) methacrylate-embedded 5 μm sections of the proximal tibial metaphysis, and (3) ultrathin calcified metaphyseal sections for electron microscopy. Cl2MDP reduced the diaphyseal medullary cavity, and EHDP increased the osteoid width. Both drugs increased end-osteal bone apposition (possibly secondarily to the repaired resorption) and, perhaps as a result, periosteal apposition was increased. Consequently, diaphyseal bone area was unchanged. Metaphyseal bone area was increased and osteoclast numbers reduced, in contrast to the increased osteoclast numbers reported previously in animal experiments with diphosphonates. Acid phosphatase activity within osteoclasts was markedly reduced with EHDP and unchanged with Cl2MDP. The ultrastructural changes in osteoclasts, i.e., a deficiency of ruffled borders, reduced numbers of cytoplasmic vacuoles and the presence of crystals between bone and the osteoclastic plasmalemma, were more marked with EHDP than Cl2MDP.

    Original languageEnglish
    Pages (from-to)290-299
    Number of pages10
    JournalClinical Orthopaedics and Related Research
    Publication statusPublished - 01 Jan 1982


    Dive into the research topics of 'The effect of long-term low-dose diphosphonate treatment on rat bone'. Together they form a unique fingerprint.

    Cite this